PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
30-Apr-2025 EVERSANA Strengthens Position as a Leading 3PL & Channel Provider with New 358,000 Square Foot Distribution Center, Expanded Cold Chain Capabilities, Enhanced Warehouse Management System and AI-Powered Robotics EVERSANA
30-Apr-2025 IFS Maven Equity Finance and the Scottish National Investment Bank back NCIMB with £1.7 million investment to drive growth NCIMB Limited
30-Apr-2025 PureTech Announces Annual Results for Year Ended December 31, 2024 PureTech Health plc
30-Apr-2025 RetinAI and FVS Announce CE-MDR Certification for Co-developed AI-based Diabetic Retinopathy Screening Algorithm, LuxIA® RetinAI and FVS
30-Apr-2025 UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus & Diphtheria Vaccine Stablepharma Ltd
30-Apr-2025 Vapourtec video showcases fully automated peptide synthesis Vapourtec
30-Apr-2025 Veranova Expands Advisory Board with Appointment of Dr. Marvin H. Caruthers Veranova
30-Apr-2025 Domain Therapeutics Presents Novel Data Addressing Key Challenges in Oncology at AACR 2025 Domain Therapeutics
30-Apr-2025 Update on CAPItello-280 Phase III trial of Truqap in metastatic castration-resistant prostate cancer AstraZeneca
30-Apr-2025 Fixed-duration Calquence-based regimens recommended for approval in the EU by CHMP for 1st-line chronic lymphocytic leukaemia AstraZeneca
30-Apr-2025 Rare Disease Day 2025: Rally for Rare Event Recap Worldwide CLinical Trials
30-Apr-2025 Addressing Uncertainty in Survival Studies Cytel
30-Apr-2025 Labcorp Announces 2025 First Quarter Results Labcorp
30-Apr-2025 Novavax Appoints Charles Newton to Board of Directors Novavax
30-Apr-2025 Guru Ramamurthy appointed as new CFO for Bayer’s Crop Science Division Bayer
30-Apr-2025 Sanofi and CD&R close Opella transaction, create global consumer healthcare leader Sanofi
30-Apr-2025 Johnson & Johnson receives FDA approval for IMAAVYTM (nipocalimab-aahu), a new FcRn blocker offering long-lasting disease control in the broadest population of people living with generalized myasthenia gravis (gMG) Johnson & Johnson
30-Apr-2025 CHMP recommends EU label update for Roche’s Phesgo to allow administration outside of clinical settings Roche
30-Apr-2025 Roche granted FDA Breakthrough Device Designation for first AI-driven companion diagnostic for non-small cell lung cancer Roche
30-Apr-2025 Gilead to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis Gilead